Does soy increase blood counts in myelodysplastic syndromes?

Detalhes bibliográficos
Autor(a) principal: Viana,T. A. O. F.
Data de Publicação: 2010
Outros Autores: Claricia,E., Pinheiro,R. F., Panizzi,M. C. C., Sandes,A. F., Carvalho,V. M., Sesso,R. C. C., Yamamoto,M., Atallah,A. N., Chauffaille,M. L. L. F.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442010000500007
Resumo: Myelodysplastic syndromes (MDS) are a group of clonal stem cell diseases characterized by ineffective hematopoiesis, bone marrow hyperproliferation, cytopenias in peripheral blood and risk of transformation into acute leukemia. We decided to investigate the effects of a soy concentrate on MDS patients based on the follow-up results of a 61 year-old Japanese female patient who was diagnosed with MDS and refractory cytopenia with multilineage dysplasia in 2003 (hemoglobin = 11g/dL; white blood cells count = 2,500/uL and platelets = 25,000/uL; marrow with mild dysplasia and normal karyotype; paroxysmal nocturnal hemoglobinuria was excluded). She started using soy as a dietary supplementation in May 2004 and presented a gradual increment in blood counts, achieving normalization approximately eight months afterwards. Among the soy components, the main compounds with anti-carcinogenic activity are the isoflavones (genistein and daidzein). Based on these lines of evidence, we proposed to administer daily a standard soy concentrate to 14 MDS out-patients for a minimum period of three months and maximum of 12 months, in an attempt to evaluate prospectively the possible increase in hemoglobin, neutrophils and platelet counts. A historical control group was used to compare results. The use of a soy concentrate in a standardized manner was associated with an increase in neutrophil and/or platelet counts in some cases, but spontaneous increments were also observed in historical controls. This preliminary study does not allow establishing a relation between soy supplementation and blood cell count increase.
id SBP-1_67a68e4a4dedccc89b8d7d3c39e6a179
oai_identifier_str oai:scielo:S1676-24442010000500007
network_acronym_str SBP-1
network_name_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository_id_str
spelling Does soy increase blood counts in myelodysplastic syndromes?SoyWhite blood countsMyelodysplastic syndromeIsoflavonesHemoglobinPlateletMyelodysplastic syndromes (MDS) are a group of clonal stem cell diseases characterized by ineffective hematopoiesis, bone marrow hyperproliferation, cytopenias in peripheral blood and risk of transformation into acute leukemia. We decided to investigate the effects of a soy concentrate on MDS patients based on the follow-up results of a 61 year-old Japanese female patient who was diagnosed with MDS and refractory cytopenia with multilineage dysplasia in 2003 (hemoglobin = 11g/dL; white blood cells count = 2,500/uL and platelets = 25,000/uL; marrow with mild dysplasia and normal karyotype; paroxysmal nocturnal hemoglobinuria was excluded). She started using soy as a dietary supplementation in May 2004 and presented a gradual increment in blood counts, achieving normalization approximately eight months afterwards. Among the soy components, the main compounds with anti-carcinogenic activity are the isoflavones (genistein and daidzein). Based on these lines of evidence, we proposed to administer daily a standard soy concentrate to 14 MDS out-patients for a minimum period of three months and maximum of 12 months, in an attempt to evaluate prospectively the possible increase in hemoglobin, neutrophils and platelet counts. A historical control group was used to compare results. The use of a soy concentrate in a standardized manner was associated with an increase in neutrophil and/or platelet counts in some cases, but spontaneous increments were also observed in historical controls. This preliminary study does not allow establishing a relation between soy supplementation and blood cell count increase.Sociedade Brasileira de Patologia Clínica2010-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442010000500007Jornal Brasileiro de Patologia e Medicina Laboratorial v.46 n.5 2010reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)instname:Sociedade Brasileira de Patologia (SBP)instacron:SBP10.1590/S1676-24442010000500007info:eu-repo/semantics/openAccessViana,T. A. O. F.Claricia,E.Pinheiro,R. F.Panizzi,M. C. C.Sandes,A. F.Carvalho,V. M.Sesso,R. C. C.Yamamoto,M.Atallah,A. N.Chauffaille,M. L. L. F.eng2010-11-10T00:00:00Zoai:scielo:S1676-24442010000500007Revistahttp://www.scielo.br/jbpmlhttps://old.scielo.br/oai/scielo-oai.php||jbpml@sbpc.org.br1678-47741676-2444opendoar:2010-11-10T00:00Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)false
dc.title.none.fl_str_mv Does soy increase blood counts in myelodysplastic syndromes?
title Does soy increase blood counts in myelodysplastic syndromes?
spellingShingle Does soy increase blood counts in myelodysplastic syndromes?
Viana,T. A. O. F.
Soy
White blood counts
Myelodysplastic syndrome
Isoflavones
Hemoglobin
Platelet
title_short Does soy increase blood counts in myelodysplastic syndromes?
title_full Does soy increase blood counts in myelodysplastic syndromes?
title_fullStr Does soy increase blood counts in myelodysplastic syndromes?
title_full_unstemmed Does soy increase blood counts in myelodysplastic syndromes?
title_sort Does soy increase blood counts in myelodysplastic syndromes?
author Viana,T. A. O. F.
author_facet Viana,T. A. O. F.
Claricia,E.
Pinheiro,R. F.
Panizzi,M. C. C.
Sandes,A. F.
Carvalho,V. M.
Sesso,R. C. C.
Yamamoto,M.
Atallah,A. N.
Chauffaille,M. L. L. F.
author_role author
author2 Claricia,E.
Pinheiro,R. F.
Panizzi,M. C. C.
Sandes,A. F.
Carvalho,V. M.
Sesso,R. C. C.
Yamamoto,M.
Atallah,A. N.
Chauffaille,M. L. L. F.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Viana,T. A. O. F.
Claricia,E.
Pinheiro,R. F.
Panizzi,M. C. C.
Sandes,A. F.
Carvalho,V. M.
Sesso,R. C. C.
Yamamoto,M.
Atallah,A. N.
Chauffaille,M. L. L. F.
dc.subject.por.fl_str_mv Soy
White blood counts
Myelodysplastic syndrome
Isoflavones
Hemoglobin
Platelet
topic Soy
White blood counts
Myelodysplastic syndrome
Isoflavones
Hemoglobin
Platelet
description Myelodysplastic syndromes (MDS) are a group of clonal stem cell diseases characterized by ineffective hematopoiesis, bone marrow hyperproliferation, cytopenias in peripheral blood and risk of transformation into acute leukemia. We decided to investigate the effects of a soy concentrate on MDS patients based on the follow-up results of a 61 year-old Japanese female patient who was diagnosed with MDS and refractory cytopenia with multilineage dysplasia in 2003 (hemoglobin = 11g/dL; white blood cells count = 2,500/uL and platelets = 25,000/uL; marrow with mild dysplasia and normal karyotype; paroxysmal nocturnal hemoglobinuria was excluded). She started using soy as a dietary supplementation in May 2004 and presented a gradual increment in blood counts, achieving normalization approximately eight months afterwards. Among the soy components, the main compounds with anti-carcinogenic activity are the isoflavones (genistein and daidzein). Based on these lines of evidence, we proposed to administer daily a standard soy concentrate to 14 MDS out-patients for a minimum period of three months and maximum of 12 months, in an attempt to evaluate prospectively the possible increase in hemoglobin, neutrophils and platelet counts. A historical control group was used to compare results. The use of a soy concentrate in a standardized manner was associated with an increase in neutrophil and/or platelet counts in some cases, but spontaneous increments were also observed in historical controls. This preliminary study does not allow establishing a relation between soy supplementation and blood cell count increase.
publishDate 2010
dc.date.none.fl_str_mv 2010-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442010000500007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442010000500007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1676-24442010000500007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
dc.source.none.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial v.46 n.5 2010
reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
instname:Sociedade Brasileira de Patologia (SBP)
instacron:SBP
instname_str Sociedade Brasileira de Patologia (SBP)
instacron_str SBP
institution SBP
reponame_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
collection Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository.name.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)
repository.mail.fl_str_mv ||jbpml@sbpc.org.br
_version_ 1752122295009148928